T S Tzai - JoVE Visualize

Showing results (1-10 of 42) with videos related to

Pageof 5

Sort By:

The Journal of Urology|February 1, 1992

Interferon-alpha can alter the lytic susceptibility of murine bladder transitional cell carcinoma (MBT-2) by their original poor specific cytotoxic tumor infiltrating lymphocytesT S Tzai, S N Lin

The Journal of Surgical Research|October 1, 1996

Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamideT S Tzai, J S Lin, N H Chow

Urologia Internationalis|January 1, 1994

Effects of chemoimmunotherapy with and without surgery in murine MBT-2 bladder tumorT S Tzai, J S Lin, N H Chow

The Journal of Urology|June 1, 1987

An alternative approach to tract dilation using optic urethrotome in percutaneous nephrolithotomyT S Tzai, C L Chang, I S Hwang

Oncology Research|January 1, 1995

Doxorubicin and cyclosporin A affect murine lymphoid cells expressing different antigenic determinantsG Zaleskis, S Verstovsek, T S Tzai, et al.

Proceedings of the National Science Council, Republic of China. Part B, Life Sciences|May 16, 2000

Postoperative administration of interleukin-12 significantly enhances the anti-tumor immune response of MBT-2 bladder cancer bearing miceT S Tzai, A L Shiau, C L Wu, et al.

European Urology|January 1, 1995

The role of transrectal ultrasonography on the palpable and impalpable abnormal prostateT S Tzai, J S Lin, Y C Yeh, et al.

Cancer Gene Therapy|February 24, 2001

Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gammaA L Shiau, C Y Lin, T S Tzai, et al.

Anticancer Research|August 6, 2000

Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class I and Fas expressionsT S Tzai, A L Shiau, L L Liu, et al.

Anticancer Research|July 23, 1998

Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancerT S Tzai, C I Lin, A L Shiau, et al.

Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:

Pageof 5

The Journal of Urology|February 1, 1992

Interferon-alpha can alter the lytic susceptibility of murine bladder transitional cell carcinoma (MBT-2) by their original poor specific cytotoxic tumor infiltrating lymphocytesT S Tzai, S N Lin

The Journal of Surgical Research|October 1, 1996

Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamideT S Tzai, J S Lin, N H Chow

Urologia Internationalis|January 1, 1994

Effects of chemoimmunotherapy with and without surgery in murine MBT-2 bladder tumorT S Tzai, J S Lin, N H Chow

The Journal of Urology|June 1, 1987

An alternative approach to tract dilation using optic urethrotome in percutaneous nephrolithotomyT S Tzai, C L Chang, I S Hwang

Oncology Research|January 1, 1995

Doxorubicin and cyclosporin A affect murine lymphoid cells expressing different antigenic determinantsG Zaleskis, S Verstovsek, T S Tzai, et al.

Proceedings of the National Science Council, Republic of China. Part B, Life Sciences|May 16, 2000

Postoperative administration of interleukin-12 significantly enhances the anti-tumor immune response of MBT-2 bladder cancer bearing miceT S Tzai, A L Shiau, C L Wu, et al.

European Urology|January 1, 1995

The role of transrectal ultrasonography on the palpable and impalpable abnormal prostateT S Tzai, J S Lin, Y C Yeh, et al.

Cancer Gene Therapy|February 24, 2001

Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gammaA L Shiau, C Y Lin, T S Tzai, et al.

Anticancer Research|August 6, 2000

Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class I and Fas expressionsT S Tzai, A L Shiau, L L Liu, et al.

Anticancer Research|July 23, 1998

Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancerT S Tzai, C I Lin, A L Shiau, et al.

Pageof 5